BIOLOGICAL · Unmapped registry intervention
sargramostim
Find medicine records ·
Find other trials using this name
Clinical trial
Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung
NCT00006483
Study summary
ClinicalTrials.govSargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Advertisement
Conditions
Kidney Cancerverified · MONDO: kidney cancer
Interventions
sargramostimBIOLOGICAL
Sponsors & collaborators
Alliance for Clinical Trials in Oncologylead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Sioux FallsSouth Dakota, United States2ReginaSaskatchewan, Canada2OmahaNebraska, United States1Ann ArborMichigan, United States1RochesterMinnesota, United States1New OrleansLouisiana, United States1ScottsdaleArizona, United States1WichitaKansas, United States1ToledoOhio, United States1PeoriaIllinois, United States1FargoNorth Dakota, United States1Des MoinesIowa, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00006483 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.